Glycogen synthase kinase 3 alteration in alzheimer disease is related to neurofibrillary tangle formation

Baum L., Seger R., Woodgett J. R., Kawabata S., Maruyama K., Koyama M., Silver J., Saitoh T. (1995) Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Mol. Brain Res.34, 1–17.

Coleman P. D., Kazee, A. M., Lapham L., Esking T., and Rogers K. (1992) Reduced GAP-43 levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer’s disease.Neurobiol. Aging 13, 631–639.

Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E. M., Biernat J., Goris J., Dorée M., and Mandelkow E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state.EMBO J. 11, 2131–2138.

Goedert M., Cohen E. S., Jakes R., and Cohen P. (1992) p42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1.FEBS Lett. 312, 95–99.

Hanger D. P., Hughes K., Woodgett J. R., Brion J., and Anderton B. H. (1992) Glycogen synthase kinase-3 induced Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.Neurosci. Lett. 147, 58–62.

Iimoto D., Masliah E., DeTeresa R., Terry R. D., and Saitoh T. (1990) Aberrant casein kinase II in Alzheimer’s disease.Brain Res. 507, 273–280.

Iqbal K., Alonso A., Gong C., Khatoon S., Kudo T., Singh T., and Grandke-Iqbal I. (1993) Molecular pathology of Alzheimer neurofibrillary degeneration.Acta Neurobiol. Expt. 53, 325–335.

Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., and Imahori K. (1992) Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments.J. Biol. Chem. 267, 10,897–10,901.

Ishiguro K., Shiratsuchi A., Sato S., Omori A., Arioka M., Kobayashi S., Uchida T., and Imahori K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments.FEBS Lett. 325, 167–172.

Jin L.-W., Masliah E., Iimoto D., DeTeresa R., Mallory M., Sundsmo M., Mori N., Sobel A., and Saitoh T. (1996) Neurofibrillary tangle-associated alteration of stathmin in Alzheimer’s disease.Neurobiol. Aging 17, 331–341.

Ledesma M. D., Correas I., Avila J., and Diaz-Nido J. (1992) Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau-protein in Alzheimer’s disease.FEBS Lett. 308, 218–224.

Mandelkow E. M. and Mandelkow E. (1993) Tau as a marker for Alzheimer’s disease.Trends Biochem. Sci. 18, 480–483.

Mandelkow E.-M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J. R., and Mandelkow E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.FEBS Lett. 314, 315–321.

Matsuo E. S., Shin R. W., Billingsley M. L., Van deVoorde A., O’Connor M., Trojanowski J. Q., and Lee V. M. (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer’s disease paired helical filament tau.Neuron 13, 989–1002.

Morishima M. and Ihara Y. (1994) Posttranslational modifications of tau in paired helical filaments.Dementia 4, 282–288.

Okazaki T., Wang H., Masliah E., Cao M., Johnson S. A., Sundsmo M., Saitoh T., and Mori N. (1995) SCG10, a neuron-specific growth-associated protein in Alzheimer’s disease.Neurobiol. Aging 16, 883–894.

Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J., and Woodgett J. R. (1992) Glycogen synthase kinase-3: functions in oncogenesis and development.Biochim. Biophys. Acta 1114, 147–162.

Price D. L. and Sisodia S. S. (1994) Cellular and molecular biology of Alzheimer’s disease and animal models.Annu. Rev. Med. 45, 435–446.

Roder H. M. and Ingram V. M. (1991) Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios.J. Neurosci. 11, 3325–3343.

Selkoe D. J. (1991) The molecular pathology of Alzheimer’s disease.Neuron 6, 487–498.

Steiner B., Mandelkow E., Biernat J., Gustke N., Meyer H. E., Schmidt B., Mieskes G., Söling H. D., Drechsel D., Kirschner M. W., Goedert M., and Mandelkow E. (1990) Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.EMBO J. 9, 3539–3544.

Sutherland C., Leighton I. A., and Cohen P. (1993) Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling.Biochem. J. 296, 15–19.

Takashima A., Noguchi K., Sato K., Hoshino T., and Imahori K. (1993) Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity.Proc. Natl. Acad. Sci. USA 90, 7789–7793.

Trojanowski J. Q. and Lee V. M. (1994) Paired helical filament τ in Alzheimer’s disease: the kinase connection.Am. J. Pathol. 144, 449–453.

Trojanowski J. Q., Schmidt M. L., Shin R. W., Bramblett G. T., Rao D., and Lee V. M. (1993) Altered tau and neurofilament proteins in neuro-degenerative diseases: Diagnostic implications for Alzheimer’s disease and Lewy body dementias.Brain Pathol. 3, 45–54.

Yang S.-D., Song J.-S., Yu J.-S., and Shiah S.-G. (1993) Protein kinase FA/GSK-3 phosphorylated τ on ser235-pro and ser404-pro that are abnormally phosphorylated in Alzheimer’s disease brain.J. Neurochem. 61, 1742–1747.